Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies

Autor: Marks, James, D'Souza, JW, Reddy, S, Goldsmith, LE, Shchaveleva, I, Marks, JD, Litwin, S, Robinson, MK

Publikováno v: Marks, James; D'Souza, JW; Reddy, S; Goldsmith, LE; Shchaveleva, I; Marks, JD; et al.(2014). Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/4n995452

© 2014 D'Souza et al.Background: Inappropriate signaling through the epidermal growth factor receptor family (EGFR1/ERBB1, ERBB2/HER2, ERBB3/HER3, and ERBB4/HER4) of receptor tyrosine kinases leads to unregulated activation of multiple downstream si

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::d2e5309ae07135af088627e78c234bec
http://www.escholarship.org/uc/item/4n995452

Modulation of UVB-induced Carcinogenesis by Activation of Alternative DNA Repair Pathways.

Autor: Sha Y; Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, 3181 S. W. Sam Jackson Park Rd, Portland, Oregon, 97239, USA.; Institute for Occupational Health Science, Shenzhen Prevention and Treatment Center for Occupational Diseases, 2019 Buxin Rd., Luohu District, Guangdong Province, Shenzhen, 518020, China., Vartanian V; Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, 3181 S. W. Sam Jackson Park Rd, Portland, Oregon, 97239, USA., Owen N; Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, 3181 S. W. Sam Jackson Park Rd, Portland, Oregon, 97239, USA., Mengden Koon SJ; Department of Dermatology, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Rd, Portland, Oregon, 97239, USA., Calkins MJ; Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, 3181 S. W. Sam Jackson Park Rd, Portland, Oregon, 97239, USA.; Institute of Cellular and Organismic Biology, Academia Sinica, 128 Academia Road, Sec. 2, Nankang, Taipei, 11529, Taiwan., Thompson CS; Encapsula NanoSciences, 6 Cadillac Dr, Suite 245, Brentwood, TN, 37027, USA., Mirafzali Z; Encapsula NanoSciences, 6 Cadillac Dr, Suite 245, Brentwood, TN, 37027, USA., Mir S; Encapsula NanoSciences, 6 Cadillac Dr, Suite 245, Brentwood, TN, 37027, USA., Goldsmith LE; Accelagen Incorporated, 6044 Cornerstone Ct W Suite C, San Diego, CA, 92121, USA., He H; Accelagen Incorporated, 6044 Cornerstone Ct W Suite C, San Diego, CA, 92121, USA., Luo C; Accelagen Incorporated, 6044 Cornerstone Ct W Suite C, San Diego, CA, 92121, USA., Brown SM; Brown Hale Consulting, Inc. 10842 Loire Ave., San Diego, CA, 92131, USA., Doetsch PW; Department of Biochemistry and Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, 30322, USA.; Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, 27709, USA., Kaempf A; Knight Cancer Institute Biostatistics Shared Resource, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Rd, Portland, Oregon, 97239, USA., Lim JY; Knight Cancer Institute Biostatistics Shared Resource, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Rd, Portland, Oregon, 97239, USA., McCullough AK; Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, 3181 S. W. Sam Jackson Park Rd, Portland, Oregon, 97239, USA.; Department of Molecular and Medical Genetics, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Rd, Portland, Oregon, 97239, USA., Lloyd RS; Oregon Institute of Occupational Health Sciences, Oregon Health & Science University, 3181 S. W. Sam Jackson Park Rd, Portland, Oregon, 97239, USA. lloydst@ohsu.edu.; Department of Molecular and Medical Genetics, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Rd, Portland, Oregon, 97239, USA. lloydst@ohsu.edu.

Publikováno v: Scientific reports [Sci Rep] 2018 Jan 15; Vol. 8 (1), pp. 705. Date of Electronic Publication: 2018 Jan 15.

Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies.

Autor: D'Souza JW; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, United States of America., Reddy S; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, United States of America., Goldsmith LE; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, United States of America., Shchaveleva I; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, United States of America., Marks JD; Department of Anesthesia and Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, United States of America., Litwin S; Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA, United States of America., Robinson MK; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, United States of America.

Publikováno v: PloS one [PLoS One] 2014 Nov 11; Vol. 9 (11), pp. e112376. Date of Electronic Publication: 2014 Nov 11 (Print Publication: 2014).

A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas.

Autor: Akazawa T; Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710, USA., Kwatra SG, Goldsmith LE, Richardson MD, Cox EA, Sampson JH, Kwatra MM

Publikováno v: Journal of neurochemistry [J Neurochem] 2009 May; Vol. 109 (4), pp. 1079-86. Date of Electronic Publication: 2009 Mar 11.

A case of organophosphorus-induced psychosis.

Autor: Conyers RA, Goldsmith LE

Publikováno v: The Medical journal of Australia [Med J Aust] 1971 Jan 02; Vol. 1 (1), pp. 27-9.